duoresp spiromax
teva pharma b.v. - budesonide, formoterol fumarate dihydrate - pulmonary disease, chronic obstructive; asthma - ravimid hingamisteede obstruktiivsete haiguste, - asthma duoresp spiromax is indicated in adults and adolescents (12 years and older) for the regular treatment of asthma, where use of a combination (inhaled corticosteroid and long-acting β₂ adrenoceptor agonist) is appropriate:in patients not adequately controlled with inhaled corticosteroids and “as needed” inhaled short-acting β₂ adrenoceptor agonists. orin patients already adequately controlled on both inhaled corticosteroids and long-acting β₂ adrenoceptor agonists. copdduoresp spiromax is indicated in adults, aged 18 years and older for the symptomatic treatment of patients with copd with forced expiratory volume in 1 second (fev₁).
symbicort turbuhaler inhalatsioonipulber
astrazeneca ab - formoterool+budesoniid - inhalatsioonipulber - 4,5mcg+160mcg 1annus 120annus 10tk; 4,5mcg+160mcg 1annus 60annus 1tk; 4,5mcg+160mcg 1annus 120annus 18tk; 4,5mcg+160mcg 1annus 60annus 18tk; 4,5mcg+160mcg 1annus 60annus 2tk; 4,5mcg+160mcg 1annus 120annus 3tk; 4,5mcg+160mcg 1annus 60annus 3tk; 4,5mcg+160mcg 1annus 60annus 10tk; 4,5mcg+160mcg 1annus 120annus 2tk; 4,5mcg+160mcg 1annus 30annus 1tk; 4,5mcg+160mcg 1annus 120annus 1tk
symbicort turbuhaler inhalatsioonipulber
astrazeneca ab - formoterool+budesoniid - inhalatsioonipulber - 9mcg+320mcg 1annus 60annus 10tk; 9mcg+320mcg 1annus 60annus 18tk; 9mcg+320mcg 1annus 60annus 1tk
bufomix easyhaler inhalatsioonipulber
orion corporation - formoterool+budesoniid - inhalatsioonipulber - 9mcg+320mcg 1annus 60annus 1tk; 9mcg+320mcg 1annus 60annus 2tk; 9mcg+320mcg 1annus 60annus 3tk
sudafed ha xylo ninasprei, lahus
mcneil healthcare (ireland) limited - ksülometasoliin - ninasprei, lahus - 0,5mg 1ml 10ml 1tk
aircosona inhalatsioonipulber kõvakapslis
pharmaswiss ceska republika s.r.o. - formoterool - inhalatsioonipulber kõvakapslis - 12mcg 60tk; 12mcg 180tk; 12mcg 120tk; 12mcg 30tk
symbicort inhalatsiooniaerosool, suspensioon
astrazeneca ab - formoterool+budesoniid - inhalatsiooniaerosool, suspensioon - 4,5mcg+160mcg 1mõõtannus 120mõõtannus
airbufo forspiro annustatud inhalatsioonipulber
sandoz pharmaceuticals d.d. - formoterool+budesoniid - annustatud inhalatsioonipulber - 4,5mcg+160mcg 1mõõtannus 60mõõtannus 2tk; 4,5mcg+160mcg 1mõõtannus 60mõõtannus 1tk
sudafed xylo ninasprei, lahus
mcneil healthcare (ireland) limited - ksülometasoliin - ninasprei, lahus - 1mg 1ml 10ml 1tk
bufomix easyhaler inhalatsioonipulber
orion corporation - formoterool+budesoniid - inhalatsioonipulber - 4,5mcg+160mcg 1annus 120annus 3tk; 4,5mcg+160mcg 1annus 120annus 1tk